News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-22 6:16:45 am Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Expanded Use Access Program Achieve Complete Clinical Response GlobeNewsWire
2024-03-22 3:30:0 am Matinas BioPharma Regains Compliance with NYSE American Continued Listing Standards GlobeNewswire
2024-02-26 5:0:0 am Matinas BioPharma Provides Positive Outcomes Update on the MAT2203 Compassionate/Expanded Use Access Program, Including Multiple Patients with Complete Clinical Resolution GlobeNewswire
2024-02-20 4:30:0 am Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis GlobeNewswire
2024-01-03 4:0:0 am Matinas BioPharma to Present at Biotech Showcase 2024 GlobeNewswire
2023-12-27 4:30:0 am Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammatory Disease Models with Oral LNC-Delivered Small Oligonucleotides GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information